報價延遲最少15分鐘:2026/04/29 12:21 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.1599 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-26.69/-0.43
|
|
企業價值
4.65M
|
| 資產負債 |
|
每股賬面淨值
9.05
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
2.55M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes. |
